Trademark applications and grants for Acorda Therapeutics Inc. Acorda Therapeutics Inc has 308 trademark applications. The latest application filed is for "AMPERA"
Patent Application | Date |
---|---|
SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION 20220296577 - 17/831209 Blight; Andrew R. ;   et al. | 2022-09-22 |
SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION 20220040161 - 17/511223 Blight; Andrew R. ;   et al. | 2022-02-10 |
SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE 20210338590 - 17/374285 Cobb, JR.; Joseph E. ;   et al. | 2021-11-04 |
METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS 20210251974 - 17/307895 Blight; Andrew R. ;   et al. | 2021-08-19 |
SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION 20210205282 - 17/203519 Blight; Andrew R. ;   et al. | 2021-07-08 |
NCAGE Code | 305Q1 | ACORDA THERAPEUTICS, INC. |
CAGE Code | 305Q1 | ACORDA THERAPEUTICS, INC. |
S.A.M. Registration | 305Q1 [963845136] | ACORDA THERAPEUTICS, INC. |
SEC | 0001008848 | ACORDA THERAPEUTICS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.